Literature DB >> 944773

Prostaglandin-macromolecule interactions. I. Noncovalent binding of prostaglandins A1, E1, F2alpha, and E2 by human and bovine serum albumins.

F L Gueriguian.   

Abstract

The binding of tritiated prostaglandins (PGA1, PGE1, PGF2alpha, and PGE2) to human and bovine serum albumins was studied by equilibrium dialysis and batchwise gel equilibration with Sephadex G-25. During equilibrium dialysis (36 hours, 4 degrees C), about half of the PGEs, but not PGA and PGF2alpha, were transformed into dehydration products; by contrast, equilibration of the prostaglandins was attained in less than a half-hour by the batchwise use of Sephadex G-25 at 25 degrees C, with no detectable ligand instability. The values of the apparent association constants for albumin-prostaglandin interactions were inversely related to the protein concentration in the assay systems. "True" apparent association constants (NKo) were measured by extrapolation to zero protein concentration. The NKo values were estimated to be 9.4 X 10(4), 2.7 X 10(4), 9 X 10(3) and 6 X 10(3) M-1 for the interaction of human serum albumin with PGA1, PGE1, PGF2alpha and PGE2, respectively. Very similar values were found for the corresponding bovine serum albumin-Prostaglandin interactions. When comparable, the data obtained by both methods were in excellent agreement. Our results were also in agreement with published values for PGA1 and PGF2alpha, both of which are relatively stable in neutral aqueous phase. Batchwise gel equilibration appears to be a useful method, if thermodynamically valid data are desired in the presence of possible ligand and/or "receptor" instability. We conclude that albumin binding probably affords circulating PGA1 a modest protection from its clearance mechanisms.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 944773

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  8 in total

1.  Structural insights into human serum albumin-mediated prostaglandin catalysis.

Authors:  Jinsheng Yang; Charles E Petersen; Chung-Eun Ha; Nadhipuram V Bhagavan
Journal:  Protein Sci       Date:  2002-03       Impact factor: 6.725

2.  Characterization of prostaglandin E2 production by Candida albicans.

Authors:  John R Erb-Downward; Mairi C Noverr
Journal:  Infect Immun       Date:  2007-04-30       Impact factor: 3.441

3.  Kinetics of prostaglandin production in various inflammatory lesions, measured in draining lymph.

Authors:  M G Johnston; J B Hay; H Z Movat
Journal:  Am J Pathol       Date:  1979-04       Impact factor: 4.307

4.  Blood plasma influences anti-aggregatory potency of prostaglandins: effect of albumin.

Authors:  G Kobzar; V Mardla; I Järving; N Samel
Journal:  Inflammopharmacology       Date:  1999       Impact factor: 4.473

5.  Alveolar response to experimental Pneumocystis carinii pneumonia in the rat.

Authors:  P N Lanken; M Minda; G G Pietra; A P Fishman
Journal:  Am J Pathol       Date:  1980-06       Impact factor: 4.307

6.  Effects of PPAR-γ agonists on oral cancer cell lines: Potential horizons for chemopreventives and adjunctive therapies.

Authors:  Jeffrey A Hall; Mark Rusten; Raed D Abughazaleh; Beverly Wuertz; Vannesa Souksavong; Paul Escher; Frank Ondrey
Journal:  Head Neck       Date:  2020-06-09       Impact factor: 3.147

7.  Effects of sulphasalazine and its metabolites on prostaglandin synthesis, inactivation and actions on smooth muscle.

Authors:  J R Hoult; P K Moore
Journal:  Br J Pharmacol       Date:  1980-04       Impact factor: 8.739

8.  The distribution of prostaglandins in afferent and efferent lymph from inflammatory sites.

Authors:  M G Johnston; J B Hay; H Z Movat
Journal:  Am J Pathol       Date:  1980-06       Impact factor: 4.307

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.